Equities research analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 41.2 % NASDAQ SRNE opened at $0.03 on Wednesday. The firm’s fifty day moving average price is […]
Related Keywords
Wisconsin , United States , , Millennium Management , Norges Bank , Squarepoint Ops , Sorrento Therapeutics Inc , Sorrento Therapeutics Company Profile , Sorrento Therapeutics , Get Free Report , Therapeutics Trading Down , Wisconsin Investment Board , Sorrento Therapeutics Daily , Nasdaq Srne , Srne , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.